CHECKPOINT THERAPEUTICS INCCHECKPOINT THERAPEUTICS INCCHECKPOINT THERAPEUTICS INC

CHECKPOINT THERAPEUTICS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪147.90 M‬EUR
−1.29EUR
‪−46.97 M‬EUR
‪93.32 K‬EUR
‪35.94 M‬
Beta (1Y)
1.41
Employees (FY)
23
Change (1Y)
−1 −4.17%
Revenue / Employee (1Y)
‪4.06 K‬EUR
Net income / Employee (1Y)
‪−2.04 M‬EUR

About Checkpoint Therapeutics, Inc.


CEO
James F. Oliviero
Headquarters
Waltham
Founded
2014
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CZTA is 3.04 EUR — it has decreased by −2.90% in the past 24 hours. Watch CHECKPOINT THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CHECKPOINT THERAPEUTICS INC stocks are traded under the ticker CZTA.
CZTA stock has fallen by −11.73% compared to the previous week, the month change is a 0.33% rise, over the last year CHECKPOINT THERAPEUTICS INC has showed a 70.79% increase.
We've gathered analysts' opinions on CHECKPOINT THERAPEUTICS INC future price: according to them, CZTA price has a max estimate of 19.18 EUR and a min estimate of 6.71 EUR. Watch CZTA chart and read a more detailed CHECKPOINT THERAPEUTICS INC stock forecast: see what analysts think of CHECKPOINT THERAPEUTICS INC and suggest that you do with its stocks.
CZTA reached its all-time high on Jan 13, 2023 with the price of 7.33 EUR, and its all-time low was 1.28 EUR and was reached on Sep 27, 2023. View more price dynamics on CZTA chart.
See other stocks reaching their highest and lowest prices.
CZTA stock is 1.67% volatile and has beta coefficient of 1.41. Track CHECKPOINT THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is CHECKPOINT THERAPEUTICS INC there?
Today CHECKPOINT THERAPEUTICS INC has the market capitalization of ‪147.90 M‬, it has decreased by −15.76% over the last week.
Yes, you can track CHECKPOINT THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
CHECKPOINT THERAPEUTICS INC is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
CZTA earnings for the last quarter are −0.17 EUR per share, whereas the estimation was −0.13 EUR resulting in a −26.80% surprise. The estimated earnings for the next quarter are −0.15 EUR per share. See more details about CHECKPOINT THERAPEUTICS INC earnings.
CHECKPOINT THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, despite the estimated figure of ‪18.26 K‬ EUR. In the next quarter, revenue is expected to reach 0.00 EUR.
CZTA net income for the last quarter is ‪−8.73 M‬ EUR, while the quarter before that showed ‪−6.23 M‬ EUR of net income which accounts for −40.26% change. Track more CHECKPOINT THERAPEUTICS INC financial stats to get the full picture.
No, CZTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 21, 2025, the company has 23.00 employees. See our rating of the largest employees — is CHECKPOINT THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHECKPOINT THERAPEUTICS INC EBITDA is ‪−33.69 M‬ EUR, and current EBITDA margin is ‪−50.63 K‬%. See more stats in CHECKPOINT THERAPEUTICS INC financial statements.
Like other stocks, CZTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHECKPOINT THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHECKPOINT THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHECKPOINT THERAPEUTICS INC stock shows the buy signal. See more of CHECKPOINT THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.